Canadian company recalls bipolar disorder drug.
D018692:Antimanic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000188:drug therapy*; D002170:Canada; D004335:Drug and Narcotic Control; D006801:Humans; D016651:Lithium Carbonate / Q000008:administration & dosage / Q000009:adverse effects*
D018692:Antimanic Agents; D016651:Lithium Carbonate